Crispr Therapeutics AG (CRSP)
US$ 38.27-2.15%
Price Chart
Key Statistics
Market Cap
$ 3.38B
P/E Ratio
0.00
Revenue (TTM)
$ 37.31M
Volume
1.3M
52W High
$ 67.88
52W Low
$ 30.04
Dividend Yield
0.00%
Beta
1.84
Technicals
50-Day MA
40.8486
200-Day MA
45.7081
52 Week High
67.88
52 Week Low
30.04
About CRSP
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISP.
Employees
393
Headquarters
Zug, Switzerland
CEO
Dr. Samarth Kulkarni Ph.D.
Latest News
CRSP June 6th Options Begin Trading - Nasdaq
3 days ago • Google News
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Legal & General Group Plc - MarketBeat
12 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg